Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 0.34 is 143% above its 4-year average of 0.14, near the high end of its 4-year range (-0.41–0.34).
As of the fiscal period ended Tuesday, June 30, 2026. 26.08% above its 12-month average of 0.27.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.34.
DEBT TO EQUITY RATIO
0.34
DEBT TO EQUITY RATIO AVG TTM
0.27
DEBT TO EQUITY RATIO AVG 3Y
0.21
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+26.08%
CURRENT VS 3Y AVG
+57.67%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 774 covered companies
CURRENT VS SECTOR MEDIAN
+204.63%
vs the sector median at left
Metagenomi, Inc. Common Stock
Market Cap
$39.15M
Debt to Equity Ratio
0.34
TTM Avg
0.27
3Y Avg
0.21
5Y Avg
N/A
Market Cap
$38.77M
Debt to Equity Ratio
5.96
TTM Avg
1.96
3Y Avg
1.31
5Y Avg
1.11
Market Cap
$40.53M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$37.72M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.02
5Y Avg
0.01
Market Cap
$37.18M
Debt to Equity Ratio
1.93
TTM Avg
0.81
3Y Avg
0.39
5Y Avg
0.65
Market Cap
$36.17M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.01
5Y Avg
0.01
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $39.15M | 0.34 | 0.27 | 0.21 | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.77M | 5.96 | 1.96 | 1.31 | 1.11 |
| Veru Inc. (VERU)vs › | $39.88M | 0.09 | 0.30 | 0.38 | 0.35 |
| Nephros, Inc. (NEPH)vs › | $38.11M | 0.07 | 0.13 | 0.17 | 0.16 |
| Filana Therapeutics, Inc. (FLNA)vs › | $40.53M | 0.00 | 0.00 | 0.00 | 0.00 |
| Incannex Healthcare Limited (IXHL)vs › | $37.72M | 0.00 | 0.01 | 0.02 | 0.01 |
| QT Imaging Holdings, Inc. (QTI)vs › | $37.18M | 1.93 | 0.81 | 0.39 | 0.65 |
| Precipio, Inc. (PRPO)vs › | $41.95M | 0.23 | 0.17 | 0.13 | 0.12 |
| Edesa Biotech, Inc. (EDSA)vs › | $36.17M | 0.00 | 0.01 | 0.01 | 0.01 |
| EUDA Health Holdings Limited (EUDA)vs › | $36.04M | N/A | 0.89 | 0.89 | 0.89 |
Debt/Equity
0.34
Current Ratio
4.50
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 0.34 |
| 2026-03-31 | 0.28 |
| 2025-12-31 | 0.26 |
| 2025-09-30 | 0.23 |
| 2025-06-30 | 0.22 |
| 2025-03-31 | 0.21 |
| 2024-12-31 | 0.19 |
| 2024-09-30 | 0.18 |
| 2024-06-30 | 0.18 |
| 2024-03-31 | 0.17 |
| 2023-12-31 | -0.36 |
| 2023-09-30 | -0.41 |
| 2023-06-30 | 0.20 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | -0.25 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 0.00 |
| 2022-03-31 | 0.00 |
